Logo: to the web site of Uppsala University

Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia. 2002 (engelsk)Inngår i: Med Oncol, ISSN 1357-0560, Vol. 19, nr 2, s. 79-86Artikkel i tidsskrift (Fagfellevurdert) Published

sted, utgiver, år, opplag, sider

2002. Vol. 19, nr 2, s. 79-86

Emneord [en]

Adult, Aged, Anemia/*complications/drug therapy/therapy, Blood Transfusion, Bone Marrow/drug effects, Female, Humans, Leprostatic Agents/administration & dosage/*adverse effects/therapeutic use, Male, Middle Aged, Myelofibrosis/complications/*drug therapy, Myeloid Metaplasia/complications/*drug therapy, Spleen/drug effects, Thalidomide/administration & dosage/*adverse effects/therapeutic use, Treatment Failure

Identifikatorer

URN: urn:nbn:se:uu:diva-73078PubMedID: 12180484OAI: oai:DiVA.org:uu-73078DiVA, id: diva2:100989

Tilgjengelig fra: 2006-05-15 Laget: 2006-05-15 Sist oppdatert: 2011-01-13

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=12180484&dopt=Citation

Av organisasjonen

Søk utenfor DiVA

GoogleGoogle ScholarTotalt: 562 treff